NASDAQ
Endonovo Therapeutics, Inc. (ENDV) has a fcf yield of -39.16% as of Friday, May 29, 2026. This represents a 92.12% decrease compared to its 12-month average of -20.38%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.